Stu022015-069 A Randomized Phase III Study Of Sublobar Resection (Sr) Versus Stereotactic Ablative Radiotherapy (Sabr) In High Risk Patients With Stage I Non-Small Cell Lung Cancer (Nsclc)
Posted Date: May 15, 2019
- Investigator: Sandra Starnes
- Specialties: Cancer, Lung Cancer, Oncology
- Type of Study: Drug
The purpose of this study is to compare the results of two standard treatments. The two treatments include sublobar resection and radiation. Sublobar resection is the removal of a small portion of a lung. Radiation, orstereotactic ablative radiotherapy, is radiation given by a specialized x-ray mach
Criteria:
To Be Eligible To Participate In This Study, Participants Must Have Lung Cancer, Or A Lung Nodule Su
Keywords:
Phase Iii, Stu-022015-069, Lung, Non-Small Cell Lung , Cancer
For More Information:
Uc Cancer Center
513-584-7698
cancer@uchealth.com